Human periodontal ligament stem cells with distinct osteogenic potential induce bone formation in rat calvaria defects
Abstract
Aim: This study aimed to evaluate the ability of human periodontal ligament stem cells (PDLSCs) with high (HP-PDLSCs) and low (LP-PDLSCs) osteogenic potential, in addition to mixed cells, to repair bone tissue. Methods: Cell phenotype, proliferation and differentiation were evaluated. Undifferentiated PDLSCs were injected into rat calvarial defects and the new bone was evaluated by μCT, histology and real-time PCR. Results: PDLSCs exhibited a typical mesenchymal stem cell phenotype and HP-PDLSCs showed lower proliferative and higher osteogenic potential than LP-PDLSCs. PDLSCs induced similar bone formation and histological analysis suggests a remodeling process, confirmed by osteogenic and osteoclastogenic markers, especially in tissues derived from defects treated with HP-PDLSCs. Conclusion: PDLSCs induced similar bone formation irrespective of their in vitro osteogenic potential.
Plain language summary
Bone is one of the most transplanted tissues worldwide and cell-based therapies has been investigated as an alternative for the treatment of bone defects. Dental tissues have been investigated as sources of stem cells and the periodontal ligament has been shown to be a viable source of these cells. Stem cells from periodontal ligament induce significant bone formation in rat calvaria defects and are safe for cell-based therapies, as the cells remain at the bone defect site for up to 4 weeks and do not migrate to vital organs, such as brain, heart, lungs, spleen, kidneys, and liver in the same period. In addition, immune responses were not detected. Considering that, stem cells from periodontal ligament can be useful in cell therapy strategies to induce bone regeneration.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Autograft, allograft, and bone graft substitutes: clinical evidence and indications for use in the setting of orthopaedic trauma surgery. J. Orthop. Trauma 33(4), 203–213 (2019).
- 2. Advances in osteobiologic materials for bone substitutes. J. Tissue Eng. Regen. Med. 12(6), 1448–1468 (2018).
- 3. Tissue engineering strategies for promoting vascularized bone regeneration. Bone 83, 197–209 (2016).
- 4. . Association of mesenchymal stem cells and osteoblasts for bone repair. Regen. Med. 10(2), 127–133 (2015).
- 5. Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation. Gene Ther. 28, 748–759 (2021).
- 6. Cell therapy: effect of locally injected mesenchymal stromal cells derived from bone marrow or adipose tissue on bone regeneration of rat calvarial defects. Sci. Rep. 9(1), 13476 (2019).
- 7. . The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3(4), 393–403 (1970).
- 8. A systematic review of the clinical applications and complications of bone marrow aspirate concentrate in management of bone defects and nonunions. Int. Orthop. 41(11), 2213–2220 (2017).
- 9. . Morbidity associated with bone marrow aspiration and trephine biopsy – a review of UK data for 2004. Haematologica 91(9), 1293–1294 (2006).
- 10. Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy. Transplant. Proc. 45(1), 434–439 (2013).
- 11. Periodontal ligament stem cells: current knowledge and future perspectives. Stem Cells Dev. 28(15), 995–1003 (2019).
- 12. Mesenchymal stem cell properties of periodontal ligament cells from deciduous and permanent teeth. J. Periodontol. 81(8), 1207–1215 (2010).
- 13. . Isolation and characterization of multipotent human periodontal ligament stem cells. Orthod. Craniofac. Res. 10(3), 149–160 (2007).
- 14. Investigation of multipotent postnatal stem cells from human periodontal ligament. The Lancet 364(9429), 149–155 (2004).
- 15. Stemness maintenance properties in human oral stem cells after long-term passage. Stem Cells Int. 2017, 5651287 (2017).
- 16. Proteome of human stem cells from periodontal ligament and dental pulp. PLoS One 8(8), e71101 (2013).
- 17. . Characterization of the osteogenic potential of mesenchymal stem cells from human periodontal ligament based on cell surface markers. Int. J. Oral Sci. 7(4), 213–219 (2015).
- 18. Stem cell properties of human periodontal ligament cells. J. Periodontal Res. 41(4), 303–310 (2006).
- 19. Characterization of highly osteoblast/cementoblast cell clones from a CD105-enriched periodontal ligament progenitor cell population. J. Periodontol. 85(6), e205–211 (2014).
- 20. Potential of periodontal ligament cells to regenerate alveolar bone. J. Oral Biosci. 52(2), 72–80 (2010).
- 21. DNMT1 inhibitor restores RUNX2 expression and mineralization in periodontal ligament cells. DNA Cell Biol. 40(5), 662–674 (2021). •• The authors characterized the human PDLSCs used in our study in terms of osteogenic differentiation potential.
- 22. . Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 15(4), 546–557 (1997).
- 23. . Biodistribution and retention of locally administered human mesenchymal stromal cells: quantitative polymerase chain reaction-based detection of human DNA in murine organs. Cytotherapy. 19(3), 384–394 (2017).
- 24. . Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25(7), 1468–1486 (2010).
- 25. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8(4), 315–317 (2006).
- 26. . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31(10), 890–896 (2003).
- 27. . Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 15(9), 1054–1061 (2013).
- 28. . Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66(6), 876–888 (1999).
- 29. . Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats. Tissue Cell 49(3), 369–375 (2017).
- 30. Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits. Graefes Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 256(1), 125–134 (2018).
- 31. A combination of intrathecal and intramuscular application of human mesenchymal stem cells partly reduces the activation of necroptosis in the spinal cord of SOD1G93A rats. Stem Cells Transl. Med. 8(6), 535–547 (2019).
- 32. . A Tetra-PEG hydrogel based aspirin sustained release system exerts beneficial effects on periodontal ligament stem cells mediated bone regeneration. Front. Chem. 7, 682 (2019).
- 33. . Coordinating cell proliferation and differentiation: antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle Georget. Tex. 15(2), 196–212 (2016).
- 34. . Stem cells derived from “inflamed” and healthy periodontal ligament tissues and their sheet functionalities: a patient-matched comparison. J. Clin. Periodontol. 43(1), 72–84 (2016).
- 35. Genome-wide DNA (hydroxy) methylation reveals the individual epigenetic landscape importance on osteogenic phenotype acquisition in periodontal ligament cells. J. Periodontol. 1–14 (2021). • The authors investigated the mechanisms involved in the distinct osteogenic potential of human PDLSCs used in our study.
- 36. Alveolar bone regeneration by transplantation of periodontal ligament stem cells and bone marrow stem cells in a canine peri-implant defect model: a pilot study. J. Periodontol. 80(11), 1815–1823 (2009).
- 37. . Biodistribution of mesenchymal stem/stromal cells in a preclinical setting. Stem Cells Int. 2013, 678063 (2013).
- 38. Biodistribution studies for cell therapy products: current status and issues. Regen. Ther. 18, 202–216 (2021).
- 39. . Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration. World J. Stem Cells [Internet]. 11(9), (2019). https://pubmed.ncbi.nlm.nih.gov/31616538/
- 40. Role of embryonic origin on osteogenic potential and bone repair capacity of rat calvarial osteoblasts. J. Bone Miner. Metab. 38(4), 481–490 (2020).
- 41. . Periodontal ligament versus bone marrow mesenchymal stem cells in combination with Bio-Oss scaffolds for ectopic and in situ bone formation: a comparative study in the rat. J. Biomater. Appl. 29(2), 243–253 (2014).
- 42. Effect of cell therapy with osteoblasts differentiated from bone marrow or adipose tissue stromal cells on bone repair. Regen. Med. 14(12), 1107–1119 (2019). •• Our group described the animal and defect models used here.